{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:40:02Z","timestamp":1716586802168},"reference-count":26,"publisher":"Elsevier BV","issue":"19","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2014.02.044","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T01:00:34Z","timestamp":1394154034000},"page":"2204-2208","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events"],"prefix":"10.1016","volume":"32","author":[{"given":"A.","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2014.02.044_bib0005","article-title":"Vaccine preventable diseases and vaccination coverage in Australia, 2001 to 2002","volume":"12\/28","author":"Brotherton","year":"2004","journal-title":"Communicable Diseases Intelligence"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2014.02.044_bib0010","first-page":"S1","article-title":"Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005","volume":"31","author":"Brotherton","year":"2007","journal-title":"Communicable Diseases Intelligence"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0015","series-title":"The Australian immunisation handbook","author":"National Health and Medical Research Council","year":"2003"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0020","series-title":"Flu (influenza) vaccine and children: what WA parents need to know","author":"Department of Health, Government of Western Australia","year":"2013"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0025","series-title":"$44 million to protect those most at risk from seasonal flu","author":"Australian Government Department of Health and Ageing","year":"2013"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0030","series-title":"Pandemic flu vaccine approved for children","author":"Australian Government Department of Health and Ageing","year":"2013"},{"issue":"1","key":"10.1016\/j.vaccine.2014.02.044_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/erv.10.143","article-title":"Panvax\u00ae: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009","volume":"10","author":"McVernon","year":"2011","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0040","series-title":"Panvax\u00ae H1N1 approval for registration for use in Australia by the Therapeutic Goods Administration (TGA)","author":"CSL Biotherapies","year":"2009"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.02.044_bib0045","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/bmjopen-2010-000016","article-title":"Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine","volume":"1","author":"Armstrong","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0050","series-title":"Seasonal flu vaccine and young children","author":"Australian Government Department of Health and Ageing","year":"2010"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2014.02.044_bib0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja11.10941","article-title":"Adverse events associated with 2010 CSL and other inactivated influenza vaccines","volume":"195","author":"Kelly","year":"2011","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0060","series-title":"Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children","author":"Therapeutic Goods Administration","year":"2010"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0065","series-title":"Seasonal flu vaccine remains suspended for young children without risk factors \u2013 advice from the Chief Medical Officer","author":"Australian Government Department of Health and Ageing","year":"2010"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0070","series-title":"Medicare: Australian Childhood Immunisation Register","author":"Australian Government Department of Human Services","year":"2013"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0075","first-page":"55","article-title":"Measuring immunisation coverage in Australia. A review of the Australian Childhood Immunisation Register","volume":"28","author":"Hull","year":"1999","journal-title":"Australian Family Physician"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0080","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1016\/j.vaccine.2010.08.062","article-title":"Post-licensure comparison of the safety profile of diphtheria\/tetanus\/whole cell pertussis\/haemophilus influenza type b vaccine and a 5-in-1 diphtheria\/tetanus\/acellular pertussis\/haemophilus influenza type b\/polio vaccine in the United Kingdom","volume":"28","author":"Andrews","year":"2010","journal-title":"Vaccine"},{"issue":"July (32)","key":"10.1016\/j.vaccine.2014.02.044_bib0085","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.vaccine.2011.05.054","article-title":"Trivalent influenza vaccine and febrile adverse events in Australia 2010, clinical features and potential mechanisms","volume":"29","author":"Blyth","year":"2011","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2014.02.044_bib0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2010.tb04029.x","article-title":"Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia","volume":"193","author":"Gold","year":"2010","journal-title":"Medical Journal of Australia"},{"issue":"37","key":"10.1016\/j.vaccine.2014.02.044_bib0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2807\/ese.15.37.19661-en","article-title":"Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010","volume":"15","author":"Kelly","year":"2010","journal-title":"Eurosurveillance"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2014.02.044_bib0100","first-page":"263","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2010","volume":"35","author":"Mahajan","year":"2011","journal-title":"Communicable Diseases Intelligence"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.02.044_bib0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/INF.0b013e31823d5303","article-title":"Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia","volume":"31","author":"Wood","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"16","key":"10.1016\/j.vaccine.2014.02.044_bib0110","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.vaccine.2011.02.012","article-title":"Fever following administration of two inactivated influenza vaccines \u2013 a survey of parents of New Zealand infants and children 5 years of age and under","volume":"29","author":"Petousis-Harris","year":"2011","journal-title":"Vaccine"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2014.02.044_bib0115","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/j.vaccine.2012.05.052","article-title":"Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance","volume":"30","author":"Petousis-Harris","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0120","series-title":"Temporary suspension of WA paediatric (6 months to 5 years) seasonal influenza vaccine program: Urgent request for information from immunisation providers","author":"Department of Health, Government of Western Australia","year":"2013"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0125","series-title":"Australian Childhood Immunisation Register (ACIR) statistics: percentage of valid vaccinations supplied to the Immunisation register by the type and State or Territory of the immunising provider","author":"Medicare Australia","year":"2010"},{"key":"10.1016\/j.vaccine.2014.02.044_bib0130","series-title":"Medicare for providers","author":"Australian Government Department of Human Services","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:23:23Z","timestamp":1716585803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X14002291"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}